Key result
Arrhythmogenic cardiomyopathy diagnosis and management transition from a phenotype-first to a genotype-first framework.
Why the study?
ACM carries a significant risk of sudden cardiac death, and its understanding and framing are shifting from a phenotype-first to a genotype-first framework for diagnosis and management.
Answers are grounded in this paper and cite their sources.
This review highlights the current transition from a phenotype-first to a genotype-first framework for the diagnosis and management of arrhythmogenic cardiomyopathy.
Arrhythmogenic cardiomyopathy (ACM) is a form of inheritable cardiomyopathy characterized by ventricular scarring and/or fibro-fatty replacement. ACM is associated with a significant risk of sudden cardiac death due to ventricular arrhythmias, especially in young patients and endurance athletes. Aim of this review is to summarize the changing in understanding and framing of this multifaceted disease, in particular highlighting the current transition from a phenotype-first to a genotype-first framework for diagnosis and management.
No takes yet. Share an insight, caveat, or question.
Gasperetti et al. (2026) conducted a review in Arrhythmogenic cardiomyopathy. This review summarizes the changing understanding of arrhythmogenic cardiomyopathy, highlighting the transition from a phenotype-first to a genotype-first framework for diagnosis and management.
Synapse has enriched 10 related papers. Consider them for comparative context: